QGEN (Life Sciences Tools & Services) Stock Valuation & Fair Value Fairly valued
QGEN (Life Sciences Tools & Services) trades at a blended P/E of 17.2, about 25% below its historical normal valuation, with a forward growth estimate of 7.2% and a PEG of 2.40. Analysts' one-year estimates have been hit 73% of the time.
Valuation flags
- No notable valuation flags.
Frequently asked questions
Is QGEN overvalued?
At a blended P/E of 17.2 versus its historical normal P/E of 23.0, QGEN trades about 25% below its typical valuation, with a PEG of 2.40 on 7.2% forward growth. tickerseer currently rates it fairly valued.
What is QGEN's fair value and PEG?
QGEN trades at a blended P/E of 17.2 against a historical normal P/E of 23.0, a PEG of 2.40, and a forward growth estimate of 7.2%.
Has tickerseer's rating of QGEN changed?
tickerseer's rating has been fairly valued since 2026-07-31.
Industry: Life Sciences Tools & Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.